Recall Radar
All recallsMedicine & devices

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Class I Medicine & devices FDA March 11, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. This recall is in the most serious category, meaning the agency believes it can cause serious injury or death — don't finish the package or use up what's left. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
ANTHONY TRINH, 123Herbals LLC — Rosemead, CA
Severity
Class I — serious
Reported
March 11, 2026
Quantity
N/A
Recall number
D-0388-2026
Status
Ongoing
Source
FDA

Where it went

USA nationwide

Other medicine & devices recalls

See every current recall on the live dashboard →